Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes.

• Tác giả: Rowena Brook, Prahlad Ho, Hui Yin Lim, Brandon Lui, Harshal Nandurkar, Joseph Rigano, Mani Suleiman
• Ngôn ngữ: eng
• Ký hiệu phân loại: 373.236 Lower level
• Thông tin xuất bản: Netherlands : Journal of thrombosis and thrombolysis , 2025
• Bộ sưu tập: NCBI
• ID: 686016

Tóm tắt

 Increased tissue factor pathway inhibitor (TFPI) has been associated with cardiovascular disease (CVD). We aim to evaluate the predictive capability of TFPI for atherothrombotic events (ATE) in patients with chronic kidney disease (CKD) and diabetes. A prospective observational study was performed at Northern Health, Australia. Patients with CKD (estimated glomerular filtration ratio (eGFR) <
  30 ml/min/1.73m